Form 8.3 - Warehouse REIT Plc | 17-Mar-2025 | 15:15 | GlobeNewswire NA |
Form 8.3 - Renewi Plc | 17-Mar-2025 | 15:13 | GlobeNewswire NA |
Form 8.3 - Primary Health Properties Plc | 17-Mar-2025 | 15:11 | GlobeNewswire NA |
Form 8.3 - Life Science REIT Plc | 17-Mar-2025 | 15:10 | GlobeNewswire NA |
Form 8.3 - De La Rue Plc | 17-Mar-2025 | 15:08 | GlobeNewswire NA |
Form 8.3 - Crimson Tide Plc | 17-Mar-2025 | 15:06 | GlobeNewswire NA |
Form 8.3 - Assura Plc | 17-Mar-2025 | 15:05 | GlobeNewswire NA |
Form 8.3 - Warehouse REIT Plc | 14-Mar-2025 | 15:11 | GlobeNewswire NA |
Form 8.3 - Renewi Plc | 14-Mar-2025 | 15:08 | GlobeNewswire NA |
Form 8.3 - Primary Health Properties Plc | 14-Mar-2025 | 15:07 | GlobeNewswire NA |
Form 8.3 - Crimson Tide Plc | 14-Mar-2025 | 15:05 | GlobeNewswire NA |
Form 8.3 - Assura Plc | 14-Mar-2025 | 15:04 | GlobeNewswire NA |
Form 8.3 - Warehouse REIT Plc | 13-Mar-2025 | 15:07 | GlobeNewswire NA |
Form 8.3 - Renewi Plc | 13-Mar-2025 | 15:05 | GlobeNewswire NA |
Form 8.3 - Primary Health Properties Plc | 13-Mar-2025 | 15:03 | GlobeNewswire NA |
Currency | UK Pounds |
Share Price | 1,642.00p |
Change Today | -14.00p |
% Change | -0.85 % |
52 Week High | 1,984.00 |
52 Week Low | 1,494.00 |
Volume | 36,836 |
Shares Issued | 91.98m |
Market Cap | £1,510.28m |
Beta | 0.01 |
RiskGrade | 130 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 5 |
Sell | 1 |
Strong Sell | 0 |
Total | 10 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 10-Apr-25 | 05-Sep-24 |
Paid | 13-May-25 | 01-Oct-24 |
Amount | 63.00p | 30.00p |
Time | Volume / Share Price |
16:35 | 13,878 @ 1,642.00p |
16:35 | 111 @ 1,642.00p |
16:35 | 151 @ 1,642.00p |
16:35 | 16 @ 1,642.00p |
16:35 | 284 @ 1,642.00p |
CEO | Paul Stockton |
CFO | Iain Hooley |
You are here: research